BB BIOTECH AG - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 166 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
BB BIOTECH AG ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$77,964,000
+34.4%
696,976
+21.1%
1.96%
+5.4%
Q4 2018$58,027,000
-15.9%
575,719
+5.5%
1.86%
+1.9%
Q3 2018$68,957,000
+50.6%
545,7190.0%1.82%
+38.0%
Q2 2018$45,791,000
+36.4%
545,7190.0%1.32%
+42.5%
Q1 2018$33,573,000
+18.3%
545,719
+12.4%
0.93%
+16.1%
Q4 2017$28,376,000
+0.7%
485,7190.0%0.80%
+2.4%
Q3 2017$28,191,000
-8.9%
485,719
+89.9%
0.78%
-17.5%
Q2 2017$30,960,000
+7.0%
255,7190.0%0.95%0.0%
Q1 2017$28,922,000
+4.1%
255,7190.0%0.95%
-8.1%
Q4 2016$27,784,000
-34.0%
255,7190.0%1.03%
-30.5%
Q3 2016$42,089,000
+15.4%
255,7190.0%1.48%
+2.8%
Q2 2016$36,486,000
+11.1%
255,7190.0%1.44%
+10.3%
Q1 2016$32,852,000
-14.0%
255,7190.0%1.31%
+21.4%
Q4 2015$38,192,000
+9.3%
255,719
+21.4%
1.08%
-2.9%
Q3 2015$34,950,000
-19.9%
210,719
+16.6%
1.11%
-6.3%
Q2 2015$43,622,000
-0.2%
180,719
+16.6%
1.18%
-9.1%
Q1 2015$43,713,000155,0001.30%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$14,787,0002.73%
DeepCurrents Investment Group LLC 416,800$9,620,0000.33%
DUALITY ADVISERS, LP 105,668$2,439,0000.21%
EULAV Asset Management 335,000$7,732,0000.21%
Virtus ETF Advisers LLC 19,375$447,0000.19%
Hennion & Walsh Asset Management, Inc. 135,214$3,121,0000.19%
PDT Partners, LLC 110,592$2,552,0000.18%
KETTLE HILL CAPITAL MANAGEMENT, LLC 70,256$1,622,0000.16%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$3,896,0000.12%
WOODWARD DIVERSIFIED CAPITAL, LLC 8,939$206,0000.12%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders